GLP-1 receptor agonists (RAs) (exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, and dulaglutide) are widely used in the treatment of type 2 diabetes mellitus (they do not induce hypoglycaemia) and more recently to manage obesity
Simultaneously, its GLP-1 receptor agonist activity suppresses glucagon secretion, slows gastric emptying, and reduces appetite through central nervous system pathways
As more affordable Semaglutide enters the Indian market, patients globally may now have more realistic long-term access options for GLP-1 therapy through compliant personal imports facilitated by MedsPartner
Protecting your muscle tissue through nutrition and movement is a key part of any successful program
doi: 10.1093/cvr/cvae120
Read Also:- What to avoid when you take Glutone 1000 How Glutone 1000 Fights Winter Oxidative Damage A